4.6 Article

Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys

Journal

BRITISH JOURNAL OF PSYCHIATRY
Volume 197, Issue 5, Pages 378-385

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1192/bjp.bp.110.080499

Keywords

-

Categories

Funding

  1. Bristol-Myers Squibb
  2. Eli Lilly Company
  3. GlaxoSmithKline
  4. Johnson & Johnson Pharmaceuticals
  5. Ortho-McNeil Pharmaceuticals
  6. Pfizer
  7. Sanofi-Aventis
  8. United States National Institute of Mental Health [R01MH070884, R01-MH059575, RO1-MH61905]
  9. John D. and Catherine T. MacArthur Foundation
  10. Pfizer Foundation
  11. US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]
  12. Fogarty International Center [FIRCA R03-TW006481]
  13. Pan American Health Organization (PAHO)
  14. Eli Lilly & Company Foundation
  15. Shire
  16. State of Sao Paulo Research Foundation (FAPESP) [03/00204-3]
  17. Ministry of Health
  18. National Center for Public Health Protection
  19. Shenzhen Bureau of Health
  20. Shenzhen Bureau of Science, Technology, and Information
  21. Ministry of Social Protection
  22. European Commission [QLG5-1999-01042, SANCO 2004123]
  23. Piedmont Region (Italy)
  24. Fondo de Investigacion Sanitaria
  25. Instituto de Salad Carlos III, Spain [FIS 00/0028]
  26. Ministerio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]
  27. Departament de Salut
  28. Generalitat de Catalunya, Spain
  29. Instituto de Salud Carlos III [CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP]
  30. WHO (India)
  31. Japanese and European Funds through United Nations Development Group Iraq Trust Fund (UNDG ITF)
  32. Israel National Institute for Health Policy and Health Services Research
  33. National Insurance Institute of Israel
  34. Japan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]
  35. Lebanese Ministry of Public Health
  36. WHO (Lebanon)
  37. Fogarty International
  38. Act for Lebanon
  39. Janssen Cilag
  40. Eli Lilly
  41. Roche
  42. Novartis
  43. National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]
  44. National Council on Science and Technology [CONACyT-G30544- H]
  45. New Zealand Ministry of Health
  46. Alcohol Advisory Council
  47. Health Research Council
  48. WHO (Geneva)
  49. WHO (Nigeria)
  50. Federal Ministry of Health, Abuja, Nigeria
  51. Ministry of Public Health
  52. National Institute of Drug Abuse
  53. South African Department of Health
  54. University of Michigan
  55. National Institute of Mental Health [U01-MH60220]
  56. Robert Wood Johnson Foundation (RWJF) [044708]
  57. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [03/00204-3] Funding Source: FAPESP

Ask authors/readers for more resources

Background Although significant associations of childhood adversities with adult mental disorders are widely documented, most studies focus on single childhood adversities predicting single disorders. Aims To examine joint associations of 12 childhood adversities with first onset of 20 DSM-IV disorders in World Mental Health (WMH) Surveys in 21 countries. Method Nationally or regionally representative surveys of 51 945 adults assessed childhood adversities and lifetime DSM-IV disorders with the WHO Composite International Diagnostic Interview (CIDI). Results Childhood adversities were highly prevalent and interrelated. Childhood adversities associated with maladaptive family functioning (e.g. parental mental illness, child abuse, neglect) were the strongest predictors of disorders. Co-occurring childhood adversities associated with maladaptive family functioning had significant subadditive predictive associations and little specificity across disorders. Childhood adversities account for 29.8% of all disorders across countries. Conclusions Childhood adversities have strong associations with all classes of disorders at all life-course stages in all groups of WMH countries. Long-term associations imply the existence of as-yet undetermined mediators.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available